Sabaa International Company for Pharmaceutical and Chemical Industry (EGX:SIPC)
Egypt flag Egypt · Delayed Price · Currency is EGP
3.660
+0.040 (1.10%)
At close: Jun 4, 2026

EGX:SIPC Income Statement

Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
54.8822.7813.3118.245.42
Revenue Growth (YoY)
140.93%71.17%-26.88%-59.93%-34.89%
Cost of Revenue
32.8519.943.5110.8926.67
Gross Profit
22.032.849.87.3118.75
Selling, General & Admin
8.696.296.485.729.85
Other Operating Expenses
0.950.99-0.04--
Operating Expenses
9.6413.76.455.739.9
Operating Income
12.39-10.863.341.588.85
Interest Expense
-0.79-1.2-1.05-1.07-0.65
Currency Exchange Gain (Loss)
--8.66-0.620-
Other Non Operating Income (Expenses)
-2.120.50.440.62
EBT Excluding Unusual Items
11.6-18.612.180.968.81
Asset Writedown
-0.05----
Pretax Income
11.55-18.612.180.968.81
Income Tax Expense
1.47-0.571.020.942.03
Net Income
10.08-18.041.160.026.78
Preferred Dividends & Other Adjustments
--0.1201.29
Net Income to Common
10.08-18.041.040.015.49
Net Income Growth
--6280.77%-99.73%-55.22%
Shares Outstanding (Basic)
252250250250250
Shares Outstanding (Diluted)
252250250250250
Shares Change (YoY)
0.84%----
EPS (Basic)
0.04-0.070.000.000.02
EPS (Diluted)
0.04-0.070.000.000.02
EPS Growth
--7075.86%-99.74%-
Free Cash Flow
10.6-2.082.09-17.293.44
Free Cash Flow Per Share
0.04-0.010.01-0.070.01
Gross Margin
40.14%12.47%73.63%40.17%41.28%
Operating Margin
22.58%-47.68%25.13%8.70%19.48%
Profit Margin
18.37%-79.19%7.82%0.08%12.09%
Free Cash Flow Margin
19.31%-9.14%15.72%-94.97%7.57%
EBITDA
15.9-7.776.565.412.06
EBITDA Margin
28.96%-34.10%49.31%29.68%26.55%
D&A For EBITDA
3.53.093.223.823.21
EBIT
12.39-10.863.341.588.85
EBIT Margin
22.58%-47.68%25.13%8.70%19.48%
Effective Tax Rate
12.72%-46.88%98.11%23.04%
Advertising Expenses
-000.03-